Divergent Outcomes in Lung Adenocarcinoma with Paraneoplastic Hypereosinophilia in Patients Treated with Pembrolizumab: A Two-Case Report
{{output}}
Paraneoplastic hypereosinophilia (PHE) is an underrecognized manifestation of solid tumors, particularly non-small cell lung cancer. We present two cases of metastatic lung adenocarcinoma with marked eosinophilia treated with PD-1 inhibitor immunotherapy, both... ...
